Skip to main content
Tuesday, November 17, 2026Nov 17

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million

FILE - A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif. (AP Photo/Barbara Ortutay, File)
FILE - A 23andMe saliva collection kit is shown on March 25, 2025, in Oakland, Calif. (AP Photo/Barbara Ortutay, File)


NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three months after 23andMe filed for Chapter 11 bankruptcy — is set to officially close in the coming weeks.

“I am thrilled that TTAM will be able to build on the mission of 23andMe to help people access, understand and benefit from the human genome,” Wojcicki said in a statement Monday — later adding that, “the future of health care belongs to all of us.”

The sale, which was approved by U.S. Bankruptcy Judge Brian C. Walsh on Friday, marks the end of a monthslong bidding war between TTAM and Regeneron Pharmaceuticals — a biotech company that had previously agreed to buy most of 23andMe’s assets for $256 million in May. But Wojcicki’s nonprofit later topped that offer, winning the final round of bidding held last month.